{"DataElement":{"publicId":"62718","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Therapy Type","preferredDefinition":"a description of therapeutic agents or procedures used to alter the pathologic process of infiltrating carcinomas before any invasion (progression) into muscularis propia of the urinary bladder wall.","longName":"SUP_BLAD_MALNE_TX_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010330","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Therapy","preferredDefinition":"related to administration of therapeutic agents to alter the pathologic process of infiltrating carcinomas that have not invaded into the muscularis propia of the urinary bladder wall.","longName":"SUP_BLAD_MAL_NEO_TX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2495260","version":"1","preferredName":"Superficial Bladder Cancer Malignant Neoplasm","preferredDefinition":"Superficial Bladder Cancer is a term used by urologists to describe infiltrating carcinomas that have not invaded into the muscularis propia of the urinary bladder wall regardless of their histologic type or grade, and therefore it does not represent a pathologic entity.  It is important for the term stage 0is bladder cancer (carcinoma in situ of the bladder) not to be equated with superficial bladder cancer.  Stage I bladder cancer may be considered superficial. --2003:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C27474:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Muscle Invasive Bladder Carcinoma","conceptCode":"C27474","definition":"An infiltrating carcinoma of the bladder that has not invaded into the bladder muscularis propria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"187D4A5D-CFB1-6372-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2324753","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-2247-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-04","modifiedBy":"ONEDATA","dateModified":"2005-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"187BF8DF-7452-59D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015397","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Therapy Type","preferredDefinition":"a description of therapeutic agents or procedures used to alter the pathologic process of infiltrating carcinomas before any invasion (progression) into muscularis propia of the urinary bladder wall.","longName":"SUP_BLAD_MALNE_TX_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intravesical chemotherapy","valueDescription":"INTRAVESICAL CHEMOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","ValueMeaning":{"publicId":"2558995","version":"1","preferredName":"INTRAVESICAL CHEMOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","longName":"2558995","preferredDefinition":"INTRAVESICAL CHEMOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B380-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E50D-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Intravesical immunotherapy","valueDescription":"INTRAVESICAL IMMUNOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","ValueMeaning":{"publicId":"2558996","version":"1","preferredName":"INTRAVESICAL IMMUNOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","longName":"2558996","preferredDefinition":"INTRAVESICAL IMMUNOTHERAPY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B381-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E517-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"None","valueDescription":"NO TREATMENT WAS GIVEN PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","ValueMeaning":{"publicId":"2559546","version":"1","preferredName":"NO TREATMENT WAS GIVEN PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","longName":"2559546","preferredDefinition":"NO TREATMENT WAS GIVEN PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E521-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Other","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E52B-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Surgery-cystectomy","valueDescription":"CYSTECTOMY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","ValueMeaning":{"publicId":"2558588","version":"1","preferredName":"CYSTECTOMY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","longName":"2558588","preferredDefinition":"CYSTECTOMY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1E9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E535-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Surgery-other","valueDescription":"OTHER SURGERY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","ValueMeaning":{"publicId":"2559669","version":"1","preferredName":"OTHER SURGERY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","longName":"2559669","preferredDefinition":"OTHER SURGERY WAS USED TO TREAT SUPERFICIAL BLADDER CANCER PRIOR TO PROGRESSION OR DIAGNOSIS OF MORE ADVANCED DISEASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B622-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E53F-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"PWEST","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Chemoradiation","valueDescription":"Chemoradiotherapy","ValueMeaning":{"publicId":"6297979","version":"1","preferredName":"Chemoradiotherapy","longName":"6297979","preferredDefinition":"Treatment that combines chemotherapy with radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemoradiotherapy","conceptCode":"C94626","definition":"Treatment that combines chemotherapy with radiation therapy. Chemoradiation can be concurrent or sequential. ","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBC02B1-C743-04AF-E053-F662850AE7B2","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CBC02B1-C75C-04AF-E053-F662850AE7B2","beginDate":"2018-05-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Radical Cystectomy","valueDescription":"Radical Cystectomy","ValueMeaning":{"publicId":"3895241","version":"1","preferredName":"Radical Cystectomy","longName":"3895241","preferredDefinition":"Surgery to remove all of the bladder (the organ that holds urine) as well as nearby tissues and organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radical Cystectomy","conceptCode":"C15396","definition":"The surgical removal of the entire bladder, a portion of the urethra, adjacent lymph nodes, and additional genitourinary structures, including the prostate and a portion of the vas deferens in men, and the ovaries, fallopian tubes, uterus, and a portion of the vagina in women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E63238B5-2E59-D377-E040-BB89AD432BC5","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CBC02B1-C766-04AF-E053-F662850AE7B2","beginDate":"2018-05-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Bladder Sparing","valueDescription":"Bladder Preservation","ValueMeaning":{"publicId":"6297980","version":"1","preferredName":"Bladder Preservation","longName":"6297980","preferredDefinition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.: The activity of protecting something from loss or danger; a process that saves organic substances from decay; to maintain or keep intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preservation","conceptCode":"C52243","definition":"The activity of protecting something from loss or danger; a process that saves organic substances from decay; to maintain or keep intact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBC02B1-C773-04AF-E053-F662850AE7B2","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CBC02B1-C78C-04AF-E053-F662850AE7B2","beginDate":"2018-05-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"187BDFDB-E4F9-56C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"MORENOC","dateModified":"2018-05-21","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Indicate any treatment receiv","type":"Preferred Question Text","description":"Indicate any treatment received before an increase in T stage >T1 or an appearance of CIS and since submission of the previous follow-up form","url":null,"context":"CTEP"},{"name":"COMMENT_383","type":"COMMENT","description":"Add instruction to form: (mark all that apply)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Progression Superficial Bladder Treatment Applied","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Management approach","url":null,"context":"Alliance"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"187BCC73-E371-54AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"MORENOC","dateModified":"2018-05-21","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}